Page 7 - Isk Bioscience News Today

S. Korea emerges as global vaccine hub May 24, 2021, 08:52 am President Moon Jae-in and US President Joe Biden hold a joint press conference at the White House in Washington on Friday. / Source: Yonhap AsiaToday reporter Choi Won-young South Korea is emerging as a global vaccine hub as Samsung and SK decided to manufacture and jointly develop COVID-19 vaccines of Moderna and Novavax. Samsung agreed to manufacture hundreds of millions of Moderna’s COVID-19 vaccine starting in the third quarter...

SK Bioscience vaccine plant gets EU approval Posted : 2021-05-17 14:59 By Kim Bo-eun SKs vaccine contract manufacturer said Monday that it received quality approval from European authorities for its plant that produces COVID-19 vaccines here. Its Andong plant in North Gyeongsang Province is manufacturㅑㅜㅎ COVID-19 vaccines for U.K. company AstraZeneca on a contract basis, and it plans to do so for U.S. firm Novavax, once drug authorities approve the vaccine. SK Bioscience said that the ...

The Latest: CDC: Vaccinated can go outside without mask The Associated Press FacebookTwitterEmail 15 1of15Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention speaks during a House Select Subcommittee on the Coronavirus Crisis on the Capitol Hill in Washington, Thursday, April 15, 2021. (Amr Alfiky/The New York Times via AP, Pool)Amr Alfiky/APShow MoreShow Less 2of15FILE - In this March 4, 2020 file photo, people walk out of an Amazon Go store, in Seattl...

The Latest: Italian police block protesting business owners The Associated Press FacebookTwitterEmail 12 1of12Demonstrators of the "Io apro" (I open) movement face police during a protest against restriction measures to curb the spread of COVID-19, in Rome, Monday, April 12, 2021. Italian restaurant owners from all over Italy and others angry at having their businesses shut for weeks due to a virus lockdown scuffled with police Monday during a non-authorized protest nearby the Parli...

The Latest: Australia has 2nd likely Astra-Zeneca clot case The Associated Press FacebookTwitterEmail 15 1of15Kerry Burke gets her second COVID-19 vaccination at a mobile clinic in Great Barrington, Mass., Monday, April 12, 2021. This particular clinic used the Moderna vaccine. (Ben Garver/The Berkshire Eagle via AP)Ben Garver/APShow MoreShow Less 2of15Karl Pajak, 28, right, and Yuting Yu, 22, fill out forms to get the Moderna vaccine at a vaccination center in the Chinatown neighbo...

The Latest: S. Korea not ruling out curbing vaccine exports The Associated Press FacebookTwitterEmail 3 1of3People wearing face masks pass by a banner displaying precautions against the coronavirus on a street in Seoul, South Korea, Monday, April 5, 2021. The banner reads " We can overcome Corona 19."Ahn Young-joon/APShow MoreShow Less 2of3A person with a protective mask to help curb the spread of the coronavirus wears samurai wig Tuesday, April 6, 2021, in Tokyo. The Japanese capit...

Credit loans surge more than 3.5 trillion won in just 2 days

SK Bioscience draws record deposits in 2-day public subscription

NH Investment likely to be top beneficiary from SK Bioscience IPO Posted : 2021-02-18 16:01 Updated : 2021-02-18 17:05 NH Investment & Securities CEO Chung Young-chae, left, and NongHyup Financial Group CEo Son Byung-hwan / Courtesy of NongHyup Financial Group NH Investment expected to earn 5.5 billion won for IPO underwriter fee By Anna J. Park With vaccine manufacturer SK Biosciences initial public offering (IPO) scheduled for next month, NH Investment & Securities is set to become the lar...

SK Bioscience to license in Novavax COVID-19 vaccine